Preclinical characterization of ABT-348, a kinase inhibitor targeting the aurora, vascular endothelial growth factor receptor/platelet-derived growth factor receptor, and Src kinase families (Q39288016)
Jump to navigation
Jump to search
scientific article published on 30 August 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical characterization of ABT-348, a kinase inhibitor targeting the aurora, vascular endothelial growth factor receptor/platelet-derived growth factor receptor, and Src kinase families |
scientific article published on 30 August 2012 |
Statements
1 reference
Preclinical characterization of ABT-348, a kinase inhibitor targeting the aurora, vascular endothelial growth factor receptor/platelet-derived growth factor receptor, and Src kinase families (English)
1 reference
Keith B Glaser
1 reference
Junling Li
1 reference
Patrick A Marcotte
1 reference
Terrance J Magoc
1 reference
Jun Guo
1 reference
David R Reuter
1 reference
Paul Tapang
1 reference
Ru-Qi Wei
1 reference
Lori J Pease
1 reference
Mai H Bui
1 reference
Zehan Chen
1 reference
Robin R Frey
1 reference
Eric F Johnson
1 reference
Donald J Osterling
1 reference
Amanda M Olson
1 reference
Jennifer J Bouska
1 reference
Yanping Luo
1 reference
Michael L Curtin
1 reference
Cherrie K Donawho
1 reference
Michael R Michaelides
1 reference
Chris Tse
1 reference
Steven K Davidsen
1 reference
Daniel H Albert
1 reference
30 August 2012
1 reference
1 reference
343
1 reference
3
1 reference
617-627
1 reference
Identifiers
1 reference
1 reference